Specialty Chemicals M&A » By The Online Investor Staff, updated Tue., Apr. 30, 6:55 AM
Recent mergers and acquisitions in the Specialty Chemicals M&A category.
Slide #4. ACETO Corporation — PACK Pharmaceuticals, LLC
Acquirer: |
ACETO Corporation (NASDAQ:ACET) |
Acquiree: |
PACK Pharmaceuticals, LLC |
Details: |
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its wholly-owned subsidiary, Rising Pharmaceuticals ("RISING"), has closed the acquisition of 100% of the equity interests of PACK Pharmaceuticals, LLC ("PACK"), a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products. The total transaction value is approximately $100 million. |
Adicet Bio is a biopharmaceutical company discovering and developing allogeneic gamma delta T cell therapies for cancer. Co.'s product candidate, ADI-001, an allogeneic gamma delta T cell therapy expressing a chimeric antigen receptors (CAR) targeting CD20, is in Phase 1 study for the treatment of Non-Hodgkin's Lymphoma. Co.'s pipeline also includes ADI-002, an allogeneic gamma delta CAR-T cell therapy expressing a GPC3-targeted CAR and a cell intrinsic soluble form of interluiken-15, for the treatment of solid tumors. In addition, Co. is engaged in preclinical stage activities directed to expansion of its pipeline of product candidates for both hematological malignancies and solid tumors.
ACET SEC Filing Email Alerts Service
Open the ACET Page at The Online Investor »
Company Name: |
Adicet Bio Inc |
Website: |
www.restorbio.com |
Sector: |
Biotechnology |
Number of ETFs Holding ACET: |
12 |
Total Market Value Held by ETFs: |
$8.48M |
Total Market Capitalization: |
$149.00M |
% of Market Cap. Held by ETFs: |
5.69% |
|
Open the ACET Page at The Online Investor (in a new window) »
|
April 30, 2024 6:55 AM Eastern
Strong Buy (3.50 out of 4)
59th percentile
|
|